Belpointe Asset Management’s Science 37 Holdings, Inc. Common Stock SNCE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-2,250
Closed -$18K 774
2023
Q3
$18K Buy
+2,250
New +$13.4K ﹤0.01% 647
2023
Q2
Sell
-2,295
Closed -$12.9K 3604
2023
Q1
$12.9K Buy
2,295
+100
+5% +$760 ﹤0.01% 2565
2022
Q4
$18.2K Buy
+2,195
New +$43K ﹤0.01% 2252

Other funds holding SNCE

Belpointe Asset Management's SNCE Position: Q4 2023 in Review

Belpointe Asset Management sold out of Science 37 Holdings, Inc. Common Stock (SNCE) in Q4 2023, closing a stake of 2,250 shares — an estimated $18K sold.

Belpointe Asset Management first reported a position in SNCE in Q4 2022 and held it in 3 quarters. The position peaked at $18.2K in Q4 2022. 29 funds tracked by Wall St. Rank hold SNCE as of Q4 2023.

  • Belpointe Asset Management reported no remaining Science 37 Holdings, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Belpointe Asset Management sold 2,250 Science 37 Holdings, Inc. Common Stock shares in Q4 2023, an estimated $18K.
  • Belpointe Asset Management first reported a position in Science 37 Holdings, Inc. Common Stock in Q4 2022 and held it in 3 quarters.
  • Belpointe Asset Management's Science 37 Holdings, Inc. Common Stock position peaked at $18.2K in Q4 2022.
  • 29 funds tracked by Wall St. Rank held Science 37 Holdings, Inc. Common Stock as of Q4 2023.

Based on Belpointe Asset Management's 13F filing for Q4 2023, filed 13 Feb 2024.